Ask The Board

  1. What Advice Do You Have For Getting Up To Speed On A New Discipline As A Leader (E.G., Your Move To Cell & Gene)? 6/1/2021

    See the answer from Charlene Banard, the global head of technical operations for cell and gene therapy at Novartis.

  2. When Your Next Job Is A Step Back From Where You Were, How Do You Manage, And What Have Been Some Of The Valuable Lessons/Insights Gained From The Experience? 6/1/2021

    See the answer from Brandi Simpson, former board chair of BioUtah and CEO of Navigen, and now a VP of business and corporate development at Voyager Therapeutics.

  3. What Is The Most Valuable Experience Gained From Your Military Training That Best Prepared You For Leading A Biopharma Company? 6/1/2021

    See the answer from John Crowley, the Chairman & CEO of Amicus Therapeutics.

  4. What Advice Do You Have On Transitioning A Career To Adjacent Industries, And How Has This Helped You In Your Role As An Executive? 5/3/2021

    See the answer from Jeff Berkowitz, CEO and director of Real Endpoints.

  5. What Best Business Practices Should A CEO Use For Determining The Various External Organization/S To Support Financially? 5/3/2021

    See the answer from Al Altomari, chairman and CEO of Agile Therapeutics.

  6. What Have Been Your Greatest Lessons Learned? 5/3/2021

    See the answer from Pamela Reilly Contag, Ph.D., CEO and president of BioEclipse Therapeutics.

  7. What Were Your Impressions Of Presenting At A Virtual JPM, And How Do You Think This Year’s Show Will Impact Future Jpms? 4/1/2021

    See the answer from Ron Cohen, M.D.; president, CEO, and founder of Acorda Therapeutics.

  8. Now That 2020 Is Behind Us, What Should We Be Paying Attention To? 4/1/2021

    See the answer from Dr. Axel Hoos, SVP, R&D governance chair, and therapeutic area head for oncology at GSK.

  9. What Advice Do You Have For Someone Aspiring To Become A Biopharma CEO? 4/1/2021

    See the answer from Tim Wright, CEO of MiMedx Group.

  10. What Do You Consider To Be A Failure? 3/1/2021

    See the answer from Chandra Ramanathan, Ph.D., the VP and head of the Bayer-AG’s U.S. east coast innovation center.